Skip to main content

and
  1. Article

    Open Access

    Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation

    To investigate the association between circulating 25-hydroxyvitamin D (25-OHD) and colorectal cancer (CRC) survival outcomes.

    **aomeng Zhang, Yazhou He, Xue Li, Rasha Shraim, Wei Xu in British Journal of Cancer (2024)

  2. Article

    Open Access

    Dissecting the pathogenic effects of smoking and its hallmarks in blood DNA methylation on colorectal cancer risk

    Tobacco smoking is suggested as a risk factor for colorectal cancer (CRC), but the complex relationship and the potential pathway are not fully understood.

    Xuan Zhou, Qian **ao, Fangyuan Jiang, **g Sun, Lijuan Wang in British Journal of Cancer (2023)

  3. Article

    Open Access

    Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis

    Rachel H. Horton, Malcolm G. Dunlop, Richard S. Houlston in British Journal of Cancer (2023)

  4. Article

    Open Access

    Phenome-wide association study (PheWAS) of colorectal cancer risk SNP effects on health outcomes in UK Biobank

    Associations between colorectal cancer (CRC) and other health outcomes have been reported, but these may be subject to biases, or due to limitations of observational studies.

    **aomeng Zhang, Xue Li, Yazhou He, Philip J. Law in British Journal of Cancer (2022)

  5. Article

    Open Access

    Genetically predicted physical activity levels are associated with lower colorectal cancer risk: a Mendelian randomisation study

    We conducted a Mendelian randomisation (MR) study to investigate whether physical activity (PA) causes a reduction of colorectal cancer risk and to understand the contributions of effects mediated through chan...

    **aomeng Zhang, Evropi Theodoratou, Xue Li in British Journal of Cancer (2021)

  6. Article

    Open Access

    The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials

    Low circulating vitamin D levels are associated with poor colorectal cancer (CRC) survival. We assess whether vitamin D supplementation improves CRC survival outcomes.

    Peter G. Vaughan-Shaw, Louis F. Buijs, James P. Blackmur in British Journal of Cancer (2020)

  7. Article

    Open Access

    Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome

    We conducted a genome-wide scan to identify non-synonymous SNPs (nsSNPs) that might influence survival after a diagnosis of colorectal cancer (CRC).

    Evropi Theodoratou, Susan M Farrington, Maria Timofeeva in British Journal of Cancer (2018)

  8. Article

    Open Access

    Erratum: Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

    Stephanie A Schubert, Dina Ruano, Fadwa A Elsayed, Arnoud Boot in British Journal of Cancer (2018)

  9. Article

    Open Access

    Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia

    A substantial fraction of familial colorectal cancer (CRC) and polyposis heritability remains unexplained. This study aimed to identify predisposing loci in patients with these disorders.

    Stephanie A Schubert, Dina Ruano, Fadwa A Elsayed, Arnoud Boot in British Journal of Cancer (2017)

  10. Article

    Open Access

    Mendelian randomisation analysis strongly implicates adiposity with risk of develo** colorectal cancer

    Observational studies have associated adiposity with an increased risk of colorectal cancer (CRC). However, such studies do not establish a causal relationship. To minimise bias from confounding we performed a...

    David Jarvis, Jonathan S Mitchell, Philip J Law, Kimmo Palin in British Journal of Cancer (2016)

  11. No Access

    Article

    Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH

    Background: Exonic deletions in MSH2 and MLH1 are significant contributors to the mutation spectrum in HNPCC, and heterozygous changes in exon copy number are not detected by conventional mutation screening metho...

    Seyed Mohammad Akrami, Malcolm G. Dunlop, Susan M. Farrington in Familial Cancer (2005)